University of British Columbia Announce World's First Clinical CBD Study on Human Volunteers

Posted on

The University of British Columbia recently announced the world's first clinical CBD study on human volunteers to determine CBD’s effectiveness at improving cardiovascular and cognitive health.

The study will utilize the latest clinical evaluation techniques to measure physiological performance, cognitive function, vascular function, and exercise performance. Participants will undergo a battery of tests which will measure things like circulating CBD, blood sugar, insulin, blood pressure, heart rate, respiration, and brain blood flow.

The double-blind study which will include 24 volunteers will be measuring effects after a single dose, and also after 7 days of daily dosing. The researchers hypothesize that circulating CBD and nitric oxide will increase in both young and old participants; that glucose and blood pressure will remain stable, and that vascular function and cognitive and physical exercise performance will improve to a greater extent in older participants.

UBC, consistently ranked one of the top three universities in Canada and one of the top research universities in the world, has conducted several earlier studies in the cannabis sector, available for review here.

Additional information will be released upon completion and interpretation of test results.